Additional investment in Medcuore Medical Solutions Private Limited
Dividend at Rs.3.75 per share
results for the quarter and year ended 31st march 2026
OUTCOME OF BOARD MEETING
OUTCOME OF BOARD MEETING
Additional Investment in Medcuore Medical Solutions Private Limited
audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2026
Outcome of Board Meeting held on 30 April, 2026 pursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations, 2015
Compliance certificate under Regulation 74(5) of SEBI DP Regulations, 2018 for the quarter ended March 31, 2026
Closure of Trading Window
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 131.85 | 171.50 | 168.32 | 168.93 | 121.15 | 127.57 | 121.63 | 97.11 | 119.44 | 119.60 | 106.31 | 107.12 |
| YOY Revenue Growth % | 0.87% | 15.14% | 12.83% | 17.98% | -8.11% | -25.62% | -27.74% | -42.52% | -1.41% | -6.25% | -12.6% | 10.31% |
| Other Income | 2.14 | 2.61 | 2.75 | 2.61 | 181.65 | 3.36 | 1.77 | 3.20 | 2.20 | 1.56 | 2.32 | 1.56 |
| Total Income | 133.98 | 174.12 | 171.08 | 171.53 | 302.80 | 130.93 | 123.40 | 100.31 | 121.64 | 121.15 | 108.63 | 108.67 |
| Total Expenses + | 137.14 | 171.97 | 162.96 | 159.22 | 138.36 | 129.05 | 135.79 | 102.95 | 120.46 | 119.65 | 117.09 | 129.17 |
| Cost of Materials Consumed | 56.61 | 58.28 | 64.06 | 56.30 | 49.71 | 49.62 | 37.68 | 32.98 | 42.47 | 40.36 | 32.62 | 43.84 |
| Employee Benefit Expense | 23.50 | 25.67 | 25.61 | 25.21 | 24.24 | 19.51 | 18.93 | 18.01 | 19.24 | 19.60 | 20.34 | 18.34 |
| Other Expenses | 26.10 | 35.43 | 33.64 | 34.43 | 35.54 | 25.99 | 35.95 | 20.12 | 24.42 | 25.07 | 26.95 | 39.36 |
| Operating Profit | -5.29 | -0.47 | 5.36 | 9.71 | -17.20 | -1.48 | -14.16 | -5.84 | -1.02 | -0.05 | -10.78 | -22.05 |
| OPM % | -4% | -0.3% | 3.2% | 5.7% | -14.2% | -1.2% | -11.6% | -6% | -0.9% | -0% | -10.1% | -20.6% |
| Profit Before Tax + | -3.15 | 2.14 | 8.12 | 12.32 | 164.44 | 1.88 | -12.39 | -2.64 | 1.19 | 1.50 | -8.46 | -20.49 |
| Tax Expense | 0.17 | -0.89 | 2.27 | 3.23 | 32.67 | -0.29 | -0.32 | -2.72 | 0.16 | 0.37 | -0.61 | 0.51 |
| Tax % | - | -41.8% | 28% | 26.2% | 19.9% | -15.5% | - | - | 13.7% | 24.4% | - | - |
| Profit After Tax | -3.33 | 3.04 | 5.84 | 9.09 | 131.77 | 2.17 | -12.07 | 0.08 | 1.02 | 1.13 | -7.85 | -21.00 |
| EPS (Basic) | -0.70 | 5.73 | 4.59 | 3.20 | 178.11 | 2.89 | -16.09 | 0.11 | 1.37 | 1.85 | -10.46 | -27.87 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 452.47 | 467.47 | 640.60 | 572.03 | 570.18 | 531.81 | 329.73 |
| YOY Revenue Growth % | -3.21% | -27.03% | 11.99% | 0.32% | 7.22% | 61.29% | - |
| Other Income | 7.64 | 189.97 | 10.11 | 5.46 | 18.76 | 18.41 | 18.29 |
| Total Income | 460.10 | 657.44 | 650.71 | 577.48 | 588.94 | 550.22 | 348.01 |
| Total Expenses + | 486.37 | 506.15 | 631.29 | 585.49 | 568.04 | 500.40 | 222.07 |
| Cost of Materials Consumed | 159.29 | 169.98 | 235.25 | 242.79 | 255.81 | 219.17 | 124.51 |
| Employee Benefit Expense | 77.52 | 80.70 | 99.99 | 85.29 | 87.09 | 81.32 | 45.13 |
| Other Expenses | 115.80 | 117.60 | 129.61 | 108.88 | 115.42 | 96.48 | 52.44 |
| Operating Profit | -33.90 | -38.68 | 9.31 | -13.47 | 2.15 | 31.41 | 107.65 |
| OPM % | -7.5% | -8.3% | 1.5% | -2.4% | 0.4% | 5.9% | 32.6% |
| Profit Before Exceptional | -26.26 | 151.29 | 19.42 | -8.01 | 20.91 | 49.82 | 30.23 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -29.23 |
| Profit Before Tax + | -26.26 | 151.29 | 19.42 | -8.01 | 20.91 | 49.82 | 1.01 |
| Tax Expense | 0.43 | 29.34 | 4.78 | 0.25 | 8.07 | 17.30 | 0.52 |
| Tax % | - | 19.4% | 24.6% | - | 38.6% | 34.7% | 51.7% |
| Profit After Tax | -26.69 | 121.95 | 14.64 | -8.26 | 12.84 | 32.51 | 0.49 |
| EPS (Basic) | -35.12 | 165.02 | 12.83 | -7.59 | 10.59 | 81.01 | 1.30 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Non-Current Assets + | 239.11 | 361.12 | 269.65 | 235.89 | 222.09 | 186.11 | 0.00 |
| Property, Plant & Equipment | 154.50 | 207.07 | 187.16 | 171.68 | 160.47 | 125.81 | 0.00 |
| Capital Work in Progress | 6.47 | 4.39 | 2.09 | 4.40 | 1.96 | 1.42 | 0.00 |
| Non-Current Investments | 60.70 | 96.14 | 0.01 | 0.01 | 0.27 | 0.00 | 0.00 |
| Goodwill | 7.01 | 0.00 | 49.41 | 49.41 | 49.41 | 49.41 | 0.00 |
| Other Intangible Assets | 8.64 | 16.16 | 17.37 | 4.82 | 5.60 | 6.62 | 0.00 |
| Current Assets + | 191.55 | 360.36 | 329.66 | 278.88 | 289.27 | 327.03 | 0.00 |
| Inventories | 61.06 | 117.20 | 96.82 | 87.55 | 116.45 | 87.21 | 0.00 |
| Trade Receivables | 58.41 | 89.54 | 132.66 | 125.55 | 94.72 | 150.79 | 0.00 |
| Cash and Cash Equivalents | 5.84 | 6.88 | 0.94 | 5.08 | 6.17 | 26.28 | 0.00 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | |||||||
| Total Equity | 307.59 | 470.91 | 273.47 | 261.91 | 275.68 | 272.64 | 0.00 |
| Equity Share Capital | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 | 0.00 |
| Other Equity | 298.80 | 434.42 | 232.43 | 227.73 | 236.45 | 238.25 | 0.00 |
| Non-Current Liabilities | 28.03 | 62.48 | 91.67 | 56.50 | 68.81 | 64.64 | 0.00 |
| Current Liabilities | 95.05 | 188.08 | 234.18 | 196.36 | 166.93 | 175.85 | 0.00 |
| Total Liabilities | 123.08 | 250.57 | 325.84 | 252.86 | 235.74 | 240.49 | 0.00 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 40.38 | -55.76 | 43.55 | 35.95 | 35.04 | 9.89 | 0.00 |
| Cash from Investing Activities | 16.81 | 80.47 | -38.26 | -27.62 | -35.41 | 8.36 | 0.00 |
| Cash from Financing Activities | -58.24 | -18.78 | -9.43 | -9.42 | -19.74 | -12.60 | 0.00 |
| Net Increase/Decrease in Cash | -1.04 | 5.94 | -4.14 | -1.09 | -20.11 | 5.13 | 0.00 |